• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

GoodRx: The Average Price Per Insulin Unit Dropped 42%

by Jasmine Pennic 01/20/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– The average price per insulin unit dropped 42%, from $0.33 in 2019 to $0.19, in mid-2024, according to a new report from GoodRx. The drop represent the lowest average recorded in a decade. 

– Thanks to the Inflation Reduction Act and voluntary price cuts by major insulin manufacturers, prices have seen significant declines. Products like Lantus, Novolin N, Humalog, and Humulin N are now more affordable than they have been in years.

Insulin Costs Plummet: A Decade-Long High Comes to an End

The struggle to afford insulin has been a major challenge for many people with diabetes, forcing some to ration their medication or even skip doses altogether. But recent policy changes and manufacturer actions are starting to make a difference. 

Key findings from the GoodRx research reveals: 

  • Insulin prices have fallen by 42% since 2019. The average price per insulin unit dropped from $0.33 in 2019 to $0.19 in mid-2024, the lowest average recorded in a decade.
  • Generics and biosimilars are driving the price decline. The introduction of generic and biosimilar versions of popular insulins has increased competition and lowered costs.
  • Traditional insulins remain the most affordable option. Older insulins like Novolin R and Novolin N have average unit prices as low as $0.02.
  • Vials are generally cheaper than pens. While pens offer convenience, they often come with a higher price tag.

Understanding the Factors Behind the Insulin Price Drop

Several factors have contributed to the recent decline in insulin prices:

  • The Inflation Reduction Act: This legislation capped insulin costs at $35 per month for Medicare beneficiaries.
  • Manufacturer price cuts: Eli Lilly and Sanofi voluntarily cut the list prices of some of their most popular insulins and capped out-of-pocket costs for commercially insured patients.
  • Generics and biosimilars: The availability of these lower-cost alternatives has increased competition and driven down prices.
  • Retail partnerships: Manufacturers have partnered with retailers like CVS and Walmart to offer discounted insulin products.

How to Save on Insulin Costs

Even with these positive trends, affording insulin can still be a challenge for many people. The report outlines best practices to help you save:

  • Use a manufacturer savings card or patient assistance program. Many insulin manufacturers offer programs that can significantly reduce or eliminate out-of-pocket costs.
  • Shop around and compare prices. GoodRx offers discounts on insulin and allows you to compare prices at different pharmacies.
  • Consider traditional insulins and vials. If cost is a major concern, talk to your doctor about switching to a more affordable traditional insulin or using vials instead of pens.
  • Appeal your insurance coverage. If your insurance plan doesn’t cover your preferred insulin, you can appeal the decision.
  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Diabetes Management, type 1 diabetes

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

HHS Finalizes HTI-4 Rule: Prior Authorization & E-Prescribing Interoperability

HHS Finalizes HTI-4 Rule: Prior Authorization & E-Prescribing Interoperability

Meaningful Use Penalties_Meaningful Use_Partial Code Free_Senators Urge CMS to Establish Clear Metrics for ICD-10 Testing

CMS Finalizes TEAM Model: A New Era of Value-Based Surgical Care

White House Event Unveils CMS Health Tech Ecosystem Initiative

White House Event Unveils CMS Health Tech Ecosystem Initiative

Digital Health Faces Q2'25 Pullback: Funding Falls to 5-Year Low, But AI Dominates and $1B+ IPOs Emerge

Healthcare Investment Shifts in 1H 2025: AI Remains a Bright Spot Amidst Fundraising Decline

Digital Health Faces Q2'25 Pullback: Funding Falls to 5-Year Low

Digital Health Faces Q2’25 Pullback: Funding Falls to 5-Year Low

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Health IT Sector Navigates Policy Turbulence with Resilient M&A

Health IT’s New Chapter: IPOs Return, Resilient M&A, Valuations Rise in 1H 2025

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

WeightWatchers Emerges from Bankruptcy, Launches New Menopause Program

WeightWatchers Emerges from Bankruptcy, Launches New Menopause Program

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |